Patents by Inventor Ming Xue

Ming Xue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8274967
    Abstract: A method, system and gateway for remotely accessing an MPLS VPN are provided. In the method, multiple virtual interfaces are established in an SSL VPN gateway, one virtual interface is bound with one VPN, different VPN users are differentiated according to authentication and authorization information of users, and the authentication and authorization information of the users is respectively bound with corresponding VPNs. When the SSL VPN gateway receives a packet sent by a user, an inner label and an outer label are added to the packet according to a VPN instance bound with the user; when receiving a response packet from a resource server, the SSL VPN gateway searches for a VPN instance according to the VPN label, and forwards the response packet to the user through the SSL connection according to the found VPN instance.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: September 25, 2012
    Assignee: Hangzhou H3C Technologies Co., Ltd.
    Inventors: Ming Xue, Xiaoping Han
  • Publication number: 20120178184
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 12, 2012
    Applicant: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
    Inventors: Jianfei YANG, Frank James KING, Jun LI, Zhen Hao QI, Ming XUE
  • Patent number: 8168752
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: May 1, 2012
    Assignee: Boehringer Ingelheim Pharmaceutical, Inc.
    Inventors: Jianfei Yang, Frank James King, Jun Li, Zhenhao Qi, Ming Xue
  • Publication number: 20110013637
    Abstract: A method, system and gateway for remotely accessing an MPLS VPN are provided. In the method, multiple virtual interfaces are established in an SSL VPN gateway, one virtual interface is bound with one VPN, different VPN users are differentiated according to authentication and authorization information of users, and the authentication and authorization information of the users is respectively bound with corresponding VPNs. When the SSL VPN gateway receives a packet sent by a user, an inner label and an outer label are added to the packet according to a VPN instance bound with the user; when receiving a response packet from a resource server, the SSL VPN gateway searches for a VPN instance according to the VPN label, and forwards the response packet to the user through the SSL connection according to the found VPN instance.
    Type: Application
    Filed: July 14, 2010
    Publication date: January 20, 2011
    Applicant: HANGZHOU H3C TECHNOLOGIES CO., LTD.
    Inventors: Ming Xue, Xiaoping Han
  • Publication number: 20100036100
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Application
    Filed: October 6, 2009
    Publication date: February 11, 2010
    Applicant: Boehringer Ingelheim Phamaceuticals, Inc.
    Inventors: Jianfei Yang, Frank James King, Jun Li, Zhen Hao Qi, Ming Xue
  • Publication number: 20060269991
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Application
    Filed: October 31, 2005
    Publication date: November 30, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jianfei Yang, Frank King, Jun Li, Zhen Qi, Ming Xue